Internal Medicine
Diabetes and COVID-19: Risks, Management, and Learnings from Other National Disasters
18 Jun, 2020 | 09:08h | UTC
Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure
18 Jun, 2020 | 09:07h | UTCInvited Commentary: Prone Positioning in Awake, Nonintubated Patients With COVID-19: Necessity Is the Mother of Invention – JAMA Internal Medicine
ACP Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination with Azithromycin for the Prophylaxis or Treatment of COVID-19?
18 Jun, 2020 | 08:59h | UTC
WHO To Include Dexamethasone in Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine from Massive Solidarity Trial
18 Jun, 2020 | 09:02h | UTCSee also: WHO drops hydroxychloroquine from Covid-19 clinical trial – STAT AND WHO halts malaria drug study, eyes steroid for COVID-19 – CIDRAP AND Steroid should be kept for serious coronavirus cases, WHO says – Reuters
Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19
18 Jun, 2020 | 09:03h | UTC
CDC Report: Characteristics Associated with Hospitalization Among Patients with COVID-19
18 Jun, 2020 | 08:57h | UTCCommentary: Black Patients With COVID-19 in Atlanta More Likely to Be Hospitalized: CDC – Reuters
No Symptoms in 37% of COVID-19 Nursing Home Patients, Research Finds
18 Jun, 2020 | 08:56h | UTCNo symptoms in 37% of COVID-19 nursing home patients, research finds – CIDRAP
Podcast: Social Determinants of Health
18 Jun, 2020 | 08:47h | UTC#220 Social Determinants of Health with Karen DeSalvo MD – The Curbsiders Internal Medicine Podcast
[Abstracts Only] Studies: Effect of Continuous Glucose Monitoring on Hypoglycemia in Patients with Type 1 Diabetes
18 Jun, 2020 | 08:42h | UTCStudy 1: Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentaries: Variable CGM benefits in high-risk subgroups – medwire News AND Continuous Glucose Monitoring Reduces Hypoglycemia in Older Adults with Type 1 Diabetes – University of North Carolina School of Medicine
Study Commentary: Haloperidol for Headache – THE HA Study RCT
18 Jun, 2020 | 08:44h | UTCHaloperidol for Headache – THE HA Study RCT – Journal Feed
Original Study: Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial – The Journal of Emergency Medicine (link to abstract – $ for full-text)
Randomized Trial: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19
17 Jun, 2020 | 02:49h | UTCCommentaries: Coronavirus breakthrough: dexamethasone is first drug shown to save lives – Nature AND WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients – World Health Organization AND Major study finds common steroid reduces deaths among patients with severe Covid-19 – STAT AND Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 – University of Oxford AND Coronavirus: Dexamethasone proves first life-saving drug – BBC
Related Commentary on Twitter
Dexamethasone reduced deaths by 1/3rd in ventilated patients (rate ratio 0.65 [95% CI 0.48 to 0.88]; p=0.0003) and by 1/5th in patients receiving oxygen only (0.80 [0.67 to 0.96]; p=0.0021). No benefit in patients not requiring respiratory support (1.22 [0.86 to 1.75; p=0.14).
— Peter Horby @peterhorby.bsky.social (@PeterHorby) June 16, 2020
Coronavirus Antibody Tests Have a Mathematical Pitfall
17 Jun, 2020 | 02:45h | UTCCoronavirus Antibody Tests Have a Mathematical Pitfall – Scientific American
How Deadly is the Coronavirus? Scientists are Close to an Answer
17 Jun, 2020 | 02:44h | UTCHow deadly is the coronavirus? Scientists are close to an answer – Nature
A Visual Guide to the SARS-CoV-2 Coronavirus
17 Jun, 2020 | 02:46h | UTCA Visual Guide to the SARS-CoV-2 Coronavirus – Scientific American
Cohort Study: Ibuprofen Use Not Associated with Worse Outcomes in Covid-19 Patients
17 Jun, 2020 | 02:41h | UTCIbuprofen use and clinical outcomes in COVID-19 patients – Clinical Microbiology and Infection
Related Commentary on Twitter
A new cohort @CMIJournal :
403 COVID-19 patients, Ibuprofen use was NOT associated with worse clinical outcomes, compared to paracetamol or no antipyretic
Ibuprofen use and clinical outcomes in #COVID19 patients.
⛔Median age : 45, younghttps://t.co/Y4WL2UsIDU— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 12, 2020
Randomized Trial: Metabolic Effects of Late Dinner in Healthy Volunteers
17 Jun, 2020 | 02:29h | UTCCommentary: People who eat a late dinner may gain weight – The Endocrine Society
Podcast: Post-Op Care and Complications
17 Jun, 2020 | 02:27h | UTC
How to Avoid the Virus as the World Reopens
16 Jun, 2020 | 08:24h | UTCHow to avoid the virus as the world reopens – Financial Times
CDC Report: Hospitalizations for Covid-19 Six Times Higher and Deaths 12 times Higher Among Those with Underlying Conditions
16 Jun, 2020 | 08:19h | UTCCommentary: COVID-19 patients with underlying health conditions are 12 times more likely to die: CDC – The Hill
Video: Coronavirus Q&A: Clinical Update with Carlos del Rio, MD
16 Jun, 2020 | 08:21h | UTCCoronavirus Q&A: Clinical Update with Carlos del Rio, MD
COVID-19 Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
16 Jun, 2020 | 08:10h | UTCCommentaries: FDA Withdraws Emergency Use Authorization For Hydroxychloroquine – NPR AND FDA revokes authorization of drug Trump touted – CNN
Natural History of Asymptomatic SARS-CoV-2 Infection
16 Jun, 2020 | 08:06h | UTCNatural History of Asymptomatic SARS-CoV-2 Infection – New England Journal of Medicine
Related: Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review – Annals of Internal Medicine AND Asymptomatic coronavirus spread is real – Vox
Thromboelastographic Results and Hypercoagulability Syndrome in Patients with Coronavirus Disease 2019 Who Are Critically Ill
16 Jun, 2020 | 07:58h | UTC
Report Suggests Some ‘Mildly Symptomatic’ Covid-19 Patients Endure Serious Long-Term Effects
16 Jun, 2020 | 07:59h | UTCRelated: COVID-19 Can Last for Several Months – The Atlantic AND Symptoms can last for weeks even in mild cases, lockdowns likely saved millions of lives – Reuters
Study: Airborne Transmission is the Dominant Route for the Spread of COVID-19
15 Jun, 2020 | 03:48h | UTCCommentaries: Face masks critical in preventing spread of COVID-19 – Texas A&M University AND Expert reaction to a study looking at mandatory face masks and number of COVID-19 infections in New York, Wuhan and Italy – Science Media Centre